Cargando…

Prognostic features in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.

This paper reports the prognostic significance of clinical and laboratory features recorded at presentation in 485 patients entered into the Medical Research Council's 3rd therapeutic trial in myelomatosis between July 1975 and August 1978. The data were complete up to 1 January 1980, with a me...

Descripción completa

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1980
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010574/ https://www.ncbi.nlm.nih.gov/pubmed/7459218

Ejemplares similares

Treatment comparisons in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.
Publicado: (1980)

Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in Adults.
por: MacLennan, I. C., et al.
Publicado: (1985)

Report on the second myelomatosis trial after five years of follow-up. Medical Research Council's Working Party on Leukaemia in Adults.
Publicado: (1980)

A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults.
por: Cuzick, J., et al.
Publicado: (1987)

Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party.
por: Hopwood, P., et al.
Publicado: (1995)

Clinico-pathological features of prognostic significance in operable rectal cancer in 17 centres in the U.K. (Third report of the M.R.C. Trial, on behalf of the Working Party).
Publicado: (1984)

Anaemia in patients with myelomatosis.
por: Ting, W. C., et al.
Publicado: (1982)

Plasma Cell Myelomatosis
por: Wahi, P. N., et al.
Publicado: (1946)

Rules of Procedure of the Council - Report by the Council Working Party
Publicado: (1968)

An overview in the treatment of advanced ovarian cancer. MRC Gynaecological Cancer Working Party.
Publicado: (1990)

A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party.
Publicado: (1992)

The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis.
por: Cuzick, J., et al.
Publicado: (1985)

Chemotherapy of acute myeloid leukaemia in adults: Medical Research Council.
Publicado: (1979)

Urinary pseudouridine excretion in myelomatosis.
por: Sørensen, S. H., et al.
Publicado: (1985)

Immunotherapy of acute myeloid leukaemia. Medical Research Council.
Publicado: (1978)

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party.
por: Bleehen, N. M., et al.
Publicado: (1991)

The late appearance of extramedullary lesions in myelomatosis.
por: Craft, I. L.
Publicado: (1967)

A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working Party.
por: Mead, G. M., et al.
Publicado: (1998)

Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosis.
por: Child, J. A., et al.
Publicado: (1983)

A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party.
por: Bleehen, N. M., et al.
Publicado: (1991)

A trial of chemotherapy in patients with osteosarcoma (a report to the Medical Research Council by their Working Party on Bone Sarcoma.
Publicado: (1986)

Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung. Medical Research Council Lung Cancer Working Party.
Publicado: (1979)

Historical perspectives on the role of the MRC: essays on the history of the Medical Research Council of the United Kingdom and its predecessor, the Medical Research Committee, 1913–1953
por: Tansey, E. M.
Publicado: (1991)

Dural Plasmacytoma with Meningeal Myelomatosis in a Patient with Multiple Myeloma
por: Gascón, Nieves, et al.
Publicado: (2018)

Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party.
Publicado: (1991)

Prevalence of Third-party Tracking on Medical Journal Websites
por: Gupta, Ravi, et al.
Publicado: (2022)

Characteristics of Facebook’s third-party medical fact checkers
por: Haslam, Alyson, et al.
Publicado: (2022)

Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring.
por: Norfolk, D., et al.
Publicado: (1980)

Third party disability of family members of adults with dysphagia
por: Coutts, Kim, et al.
Publicado: (2023)

What is the role of radiation-chemotherapy in the radical non-surgical management of carcinoma of the oesophagus? Upper GI Cancer Working Party of the UK Medical Research Council.
por: Price, P., et al.
Publicado: (1998)

Third-party JavaScript
por: Vinegar, Ben, et al.
Publicado: (2013)

Payment to a third party
Publicado: (1992)

Draft Report by the Finance Committee and Recommendations to the Council on the Report of the Working Party on the CERN Programme and Budget
Publicado: (1962)

Preclerkship Medical Students’ Use of Third-Party Learning Resources
por: Lawrence, Emily C. N., et al.
Publicado: (2023)

Progressive neurological deficits in multiple myeloma: meningeal myelomatosis without MRI abnormalities
por: van Ginkel, S., et al.
Publicado: (2011)

Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party.
por: Fayers, P. M., et al.
Publicado: (1991)

The work of the Kuru Field Unit, Kuru Research Project of the Papua New Guinea Institute of Medical Research and MRC Prion Unit
por: Pako, Wandagi H.
Publicado: (2008)

Risk-adapted approaches to the management of clinical trials: guidance from the Department of Health (DH)/Medical Research Council(MRC)/Medicines and Healthcare Products Regulatory Agency (MHRA) Clinical Trials Working Group
por: Meredith, Sarah, et al.
Publicado: (2011)

Working Parties
Publicado: (2017)

Study protocol: delayed intervention randomised controlled trial within the Medical Research Council (MRC) Framework to assess the effectiveness of a new palliative care service
por: Higginson, Irene J, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_13787ojoatvm6k1g1bgiggf9tu